References
- Asgari MM, Moffet HH, Ray GT, et al. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998–2012. JAMA Dermatol. 2015;151(9):976–981. doi:10.1001/jamadermatol.2015.1188
- Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer. 2019;118:10–34. doi:10.1016/j.ejca.2019.06.003
- Trakatelli M, Morton C, Nagore E, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014;24(3):312–329. doi:10.1684/ejd.2014.2271
- Betti R, Inselvini E, Moneghini L, et al. Giant basal cell carcinomas: report of four cases and considerations. J Dermatol. 1997;24(5):317–321. doi:10.1111/j.1346-8138.1997.tb02797.x
- Archontaki M, Stavrianos SD, Korkolis DP, et al. Giant Basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res. 2009;29(7):2655–2663.
- Lorenzini M, Gatti S, Giannitrapani A. Giant basal cell carcinoma of the thoracic wall: a case report and review of the literature. Br J Plast Surg. 2005;58(7):1007–1010. doi:10.1016/j.bjps.2005.04.017